Vinge has represented Inflexion in connection with the acquisition of the Mecenat group from IK. The acquisition of Mecenat is the first investment made through Inflexion's new Enterprise Fund VI, and Inflexion's first acquisition in Sweden.

Mecenat is a digital marketplace that connects students, alumni, young professionals, and seniors with well-known brands by offering access to exclusive deals, career services, and relevant events. The Mecenat group operates in both Sweden and Finland, has approximately three million members, and collaborates with more than 700 local and global brands. Mecenat's platform spans various industries, including technology, fashion, travel and entertainment.

Vinge's team mainly consisted of Christina Kokko, Maria Dahlin Kolvik, Eléonore Friberg, Carl Fredrik Wachtmeister, Madelene Andersson, and Chris Bastholm (M&A), Victor Ericsson (Tax), Helena Göransson, Karl-Gustaw Tobola, August Ahlin, and Matilda Hamner (Banking and Finance), Ian Jonsson and Siri Blomberg (IP), Simon Söderholm and Linn Aho (Employment), Carla Håkansson and Hanna Kövamees (Commercial Agreements), Katja Häglund (GDPR), Hayaat Ibrahim (Compliance), Nils Unckel and Anton Sjökvist (AIFMD), Lovisa Lewin and Alva Chambert (Competition Law and FDI), and Caroline Löv (Transaction Support Coordinator).

For more information, please see the client's press release here

Related

Vinge advises Sobro on its investment in Västkustens Konstruktionsbyrå

Västkustens Konstruktionsbyrå has decided to broaden its ownership structure by bringing in Sobro as a new co-partner and majority shareholder. The founders will remain with the company as the CEO and CTO respectively, and as significant shareholders. Västkustens Konstruktionsbyrå is an engineering consultancy company based in Gothenburg with cutting-edge expertise in project management, civil engineering and design.
April 23, 2026

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of SEK 350 million before transaction costs.
April 22, 2026

Vinge has advised Alder on the establishment of Alder Strategic Opportunities Fund I and on a fund credit facility agreement in connection with the fundraising

Vinge has advised Alder on the establishment of the continuation fund Alder Strategic Opportunities Fund I AB. In connection with the establishment, the fund acquires the portfolio companies SI and SMG from Alder II. Vinge also advised Alder on the entering into of a fund credit facility agreement with SEB.
April 20, 2026